← All articles

Skubal surgery sidelines Tigers ace for two to three months

Tigers ace Tarik Skubal underwent arthroscopic left elbow surgery and will miss two to three months. The injury, revealed after arm discomfort in a previous start, significantly impacts Detroit's already depleted rotation. The Tigers remain tied for the AL Central lead at 18-17 despite losing their top pitcher.

AI-assisted reporting

The essentials

Tigers ace Skubal undergoes elbow surgery, sidelined two to three months during crucial rotation crisis.

Tigers ace Tarik Skubal underwent arthroscopic surgery on his left elbow and is expected to miss two to three months following the procedure. The surgery comes after Skubal displayed arm discomfort during a start against the Braves and was subsequently scratched from his scheduled start against the Boston Red Sox.

Skubal posted a 3-2 record with a 2.70 ERA through seven starts in 2026 before the injury forced him from competition. The loss of the ace compounds existing challenges for Detroit, as the Tigers rotation is already depleted by multiple injuries. Despite the setback, the Tigers maintain a tied position for the AL Central lead with an 18-17 record, though the absence of their top pitcher threatens rotation depth going forward.

Broaden the view

Other ways to read this story.

Alternative framings generated by SigNews. These are not independent sources or attributed quotations.

Injury Timeline

From discomfort to surgery: Skubal's rapid progression to operating table

Skubal displayed arm discomfort during a start against the Braves, prompting immediate concern. The Tigers subsequently scratched him from his scheduled start against the Red Sox as a precaution. Arthroscopic surgery on his left elbow followed, with recovery expected to span two to three months. The swift progression from initial discomfort to surgical intervention reflects the serious nature of the injury.

Rotation Impact

Losing production and depth: Skubal absence strains already injured staff

Skubal's 3-2 record and 2.70 ERA represented quality 2026 production from Detroit's rotation anchor. The Tigers rotation is already depleted by multiple injuries, making his absence particularly impactful. The team faces the challenge of maintaining competitiveness—currently tied for the AL Central lead at 18-17—while managing significant pitching depth losses during his recovery period.